Join to View Full Profile
272 N Lansdowne AveLansdowne, PA 19050
Phone+1 610-259-3434
Fax+1 610-259-3480
Dr. Mooreville is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Mooreville is a urologist based in Lansdowne, PA, specializing in male sexual dysfunction, stone disease, and infections & inflammation. He completed his residency in urology at Sidney Kimmel Medical College at Thomas Jefferson University/TJUH, following his medical degree from Pennsylvania State University College of Medicine and a transitional year internship at Drexel University College of Medicine/Hahnemann University. Dr. Mooreville has been an instructor at Thomas Jefferson University Hospital since 1983. His areas of expertise include urologic oncology, minimally invasive urologic surgery, female pelvic medicine and reconstruction, kidney and ureteral stones, and andrology. He has several publications, including those on minimally invasive procedures and prostate cancer treatments, and has received various certifications for CMS Meaningful Use. He is certified by the American Board of Urology.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Urology, 1979 - 1983
Drexel University College of Medicine/Hahnemann UniversityInternship, Transitional Year, 1978 - 1979
Pennsylvania State University College of MedicineClass of 1978
Certifications & Licensure
PA State Medical License 1979 - 2026
NJ State Medical License 1983 - 2021
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Care360 EHR, MedPlus, A Quest Diagnostics Company, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification ChartMaker Medical Suite, STI Computer Services, Inc., 2012, 2014-2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 16 citationsThe Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups.A. Ricco, Genevieve Manahan, Rachelle Lanciano, Alexandra L. Hanlon, Jun Yang
Frontiers in Oncology. 2016-08-23 - 13 citationsPropensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancerCaspian Oliai, Matthew Bernetich, Luther W. Brady, Jun Yang, Alexandra L. Hanlon
Journal of Radiation Oncology. 2016-01-23 - 27 citationsSBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN ...Matthew Bernetich, Caspian Oliai, Rachelle Lanciano, Alexandra L. Hanlon, John Lamond
Frontiers in Oncology. 2014-11-11
Authored Content
- GU Cancers See More Minimally Invasive Procedures and Personalized Treatment at AUA19May 2019
- GU Cancers See More Minimally Invasive Procedures and Personalized Treatment at AUA19May 2019
Professional Memberships
- Member
- Member
Other Languages
- Italian, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
